BB's Stock Haven

[Aquahoya]

$GSTC The patent for this drug was utilized in clinical trials. It was in process to phase 3. Was ended because the patent owner was inserting his therapy/adding it illegally.

Italy makes it difficult to run clinical trials so the owner of the therapy got the patent in the US and found Jim to get the therapy through US trials.

They ran a 150 subject clinical trial with amazing results.

$GSTC Early stage #clinicaltrials #biotechnology company interested in their #FDA approved Tri-drug therapy for #multiplesclerosis with potential hospital @ApolloInter. They announced, "two strategic partnership initiatives" and awaiting clinical trials approval. @MS_HealthUnion https://t.co/w4auviZwS7 pic.twitter.com/4RnCzxXc4v

— Kevin C (@Aquahoya) January 6, 2023